# An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

> **NCT02195440** · PHASE1 · COMPLETED · sponsor: **Komagome Hospital** · enrollment: 14 (actual)

## Conditions studied

- Hepatitis C Virus-infected Cirrhosis

## Interventions

- **DRUG:** PRI-724

## Key facts

- **NCT ID:** NCT02195440
- **Lead sponsor:** Komagome Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-03-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-07-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02195440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02195440, "An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02195440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*